Printer Friendly

BLOCK DRUG COMPANY REPORTS PRELIMINARY NINE MONTH AND THIRD QUARTER SALES AND EARNINGS

 BLOCK DRUG COMPANY REPORTS PRELIMINARY
 NINE MONTH AND THIRD QUARTER SALES AND EARNINGS
 JERSEY CITY, N.J., Jan. 28 /PRNewswire/ -- Block Drug Company, Inc. (NASDAQ: BLOCA) today reported sales for the third quarter ended Dec. 31, 1991, increased by 4 percent to $138,502,000 from $132,942,000 for the same period in 1990. Net earnings after taxes rose to $13,723,000, equal to $.75 per share, compared with $13,246,000 or $.72 per shared earned a year ago.
 Sales for the first nine months were $418,043,000, an increase of 10 percent over the same period last year. Net earnings for the nine months were $42,433,000 or earnings per share of $2.31 compared to $2.12 for the same period in 1990.
 A dividend in the amount of $.225 per share has been declared payable on April 1, 1992, to Class A common stockholders of record March 2, 1991.
 BLOCK DRUG COMPANY, INC.
 Preliminary Consolidated Statements of Income(A)
 Periods ended Nine Months Quarter
 Dec. 31 1991 1990 1991 1990
 Net sales $418,043,000 $381,525,000 $138,502,000 $132,942,000
 Income before
 provision
 for taxes 54,055,000 50,385,000 17,200,000 17,240,000
 Net income 42,433,000 39,199,000 13,723,000(C) 13,246,000
 Avg. number
 of shares
 outstanding 18,369,130 18,520,284(B) 18,372,386 18,357,448(B)
 Net income
 per share $2.31(B) $2.12(B) $.75 $.72(B)
 (A) -- Unaudited.
 (B) -- Average number of shares outstanding and net income per share have been restated for the 3 percent stock dividend declared in October 1991.
 (C) -- The quarter's results include a one-time, after-tax charge of $2,647,000, representing the cost of correcting certain manufacturing difficulties which occurred at a plant operated by one of the company's international subsidiaries. Also included are after-tax gains of $1,940,000 on the sale of marketable securities.
 -0- 1/28/92
 /CONTACT: Melvin Kopp, senior vice president and controller of Block Drug Company, 201-434-3000/
 (BLOCA) CO: Block Drug Company, Inc. ST: New Jersey IN: SU: ERN


CK-TM -- NY078 -- 4364 01/28/92 15:38 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 28, 1992
Words:369
Previous Article:NORTHWEST AIRLINES HONORS SUPER BOWL VOLUNTEERS
Next Article:DYNCORP ISSUES NOTICE OF REDEMPTION


Related Articles
BLOCK DRUG COMPANY REPORTS PRELIMINARY FIRST QUARTER SALES AND EARNINGS
PERRY'S THIRD-QUARTER EARNINGS UP 39 PERCENT; SAME STORE SALES CONTINUE DOUBLE-DIGIT INCREASES
HANNAFORD REPORTS INCREASED SALES AND EARNINGS FOR THE THIRD QUARTER AND NINE MONTHS
MARION MERRELL DOW REPORTS 16 PERCENT GAIN IN THIRD-QUARTER EARNINGS PER SHARE
BLOCK DRUG COMPANY, INC. REPORTS PRELIMINARY SIX MONTHS AND SECOND QUARTER SALES AND EARNINGS
BLOCK DRUG COMPANY, INC. REPORTS PRELIMINARY NINE MONTHS AND THIRD QUARTER SALES AND EARNINGS
BLOCK DRUG COMPANY REPORTS PRELIMINARY FIRST QUARTER SALES AND EARNINGS
PERRY REPORTS ON THIRD QUARTER
CNS, INC. REPORTS THIRD QUARTER RESULTS
SYNTEX REPORTS THIRD QUARTER FISCAL 1994

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters